CLARKE JOHN K - Insider Non-Derivative Transactions at aTYR PHARMA INC (LIFE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 26, 2023, CLARKE JOHN K's relationship to aTYR PHARMA INC (LIFE) is Director, and currently has 19,797 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LIFE insiders.
Data Source: SEC.
CLARKE JOHN K - Insider Non-Derivative Transactions at LIFE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 27, 2023 | M -- (Common Stock) | 6000 | 0 | 19797 |